{
    "article_link": "https://doi.org/10.1038/s41467-024-47463-6",
    "data": [
        {
            "id": "data_1",
            "omics": "Transcriptomics (next-gen RNA-seq)",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228842",
            "format": "FASTQ/BAM",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE228842"
        },
        {
            "id": "data_2",
            "omics": "Transcriptomics (3rd-gen long-read RNA-seq)",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228842",
            "format": "FASTQ",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE228842"
        },
        {
            "id": "data_3",
            "omics": "Small RNA (sRNA) Sequencing",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228842",
            "format": "FASTQ",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE228842"
        },
        {
            "id": "data_4",
            "omics": "Serum Cytokines (Luminex)",
            "link": "https://doi.org/10.1038/s41467-024-47463-6/SourceData",
            "format": "csv",
            "source": "Supplementary Data file",
            "public_id": "Supplementary Data File: Cytokine_Luminex.csv"
        },
        {
            "id": "data_5",
            "omics": "Serum Cytokines (MSD)",
            "link": "https://doi.org/10.1038/s41467-024-47463-6/SourceData",
            "format": "csv",
            "source": "Supplementary Data file",
            "public_id": "Supplementary Data File: Cytokine_MSD.csv"
        },
        {
            "id": "data_6",
            "omics": "Serum C-Reactive Protein (CRP)",
            "link": "https://doi.org/10.1038/s41467-024-47463-6/SourceData",
            "format": "csv",
            "source": "Supplementary Data file",
            "public_id": "Supplementary Data File: CRP.csv"
        },
        {
            "id": "data_7",
            "omics": "Viral Load (RT-PCR Ct values)",
            "link": "https://doi.org/10.1038/s41467-024-47463-6/SourceData",
            "format": "csv",
            "source": "Supplementary Data file",
            "public_id": "Supplementary Data File: Ct_values.csv"
        },
        {
            "id": "data_8",
            "omics": "Cellular Composition (CIBERSORTx and Clinical Blood Count)",
            "link": "https://doi.org/10.1038/s41467-024-47463-6/SupplementaryData1",
            "format": "",
            "source": "Supplementary Data 1",
            "public_id": "Supplementary Data 1: Cellular_Composition.csv"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Differential RNA-seq Analysis (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "naat_status": [
                    "NAAT+ve",
                    "NAAT-ve"
                ],
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_2",
            "analysis_name": "Gene Set Enrichment Analysis (GSEA) (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "naat_status": [
                    "NAAT+ve",
                    "NAAT-ve"
                ],
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_3",
            "analysis_name": "Principal Component Analysis (PCA) (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": [
                    "NAAT+ve",
                    "NAAT-ve"
                ],
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "Differential RNA-seq Analysis (ChAdOx1 vs Placebo) (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "Differential Transcript Expression Analysis (3rd-gen RNA-seq) (Stage 1)",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "naat_status": [
                    "NAAT+ve",
                    "NAAT-ve"
                ],
                "time_point": "D0 vs CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "Blood Transcriptional Module (BTM) Analysis (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_7",
            "analysis_name": "Serum Cytokine Differential Analysis (Luminex) (Stage 1)",
            "analysis_data": [
                "data_4"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_8",
            "analysis_name": "CIBERSORTx Deconvolution (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": [
                    "NAAT+ve",
                    "NAAT-ve"
                ],
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_9",
            "analysis_name": "MiRNA Set Enrichment Analysis (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_10",
            "analysis_name": "Multi-omics Pathway Integration (Stage 1)",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4",
                "data_5"
            ],
            "label": {
                "omics_layers": [
                    "mRNA",
                    "miRNA",
                    "protein"
                ],
                "pathway": "Coronavirus Disease COVID-19",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_11",
            "analysis_name": "Reciprocal miRNA-mRNA Enrichment Analysis (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "omics_layers": [
                    "mRNA",
                    "miRNA"
                ],
                "enrichment_type": "opposite and same",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_12",
            "analysis_name": "GO Biological Process Analysis (mRNA) (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_13",
            "analysis_name": "Differential sRNA Analysis (Stage 1)",
            "analysis_data": [
                "data_3"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_14",
            "analysis_name": "GSEA (Stage 1, CT+7)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT+7",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_15",
            "analysis_name": "Mechanistic Analysis of MiRNA Maturation Gene Regulation (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_16",
            "analysis_name": "Alternative Splicing Analysis (MX1-201 isoform) (Stage 1)",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "gene": "MX1",
                "isoform": "MX1-201",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_17",
            "analysis_name": "Viral Load (Ctmin) Comparison Analysis (Stage 1)",
            "analysis_data": [
                "data_7"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_18",
            "analysis_name": "Serum CRP Comparison Analysis (Stage 1)",
            "analysis_data": [
                "data_6"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_19",
            "analysis_name": "MiRNA-mRNA Target Pathway Anticorrelation Analysis (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "feature": "hsa-miR-150-5p and STAT1",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_20",
            "analysis_name": "Single-cell RNA-seq Analysis (KREMEN1) (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "gene": "KREMEN1",
                "cell_type": "neutrophils",
                "dataset": "E-MTAB-9221",
                "time_point": "CT",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_21",
            "analysis_name": "Differential RNA-seq Analysis (Stage 2)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_2"
            }
        },
        {
            "id": "analysis_22",
            "analysis_name": "Differential RNA-seq Analysis (CT+7) (Stage 2)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT+7",
                "stage": "stage_2"
            }
        },
        {
            "id": "analysis_23",
            "analysis_name": "sRNA Differential Analysis (Stage 2)",
            "analysis_data": [
                "data_3"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT+7",
                "stage": "stage_2"
            }
        },
        {
            "id": "analysis_24",
            "analysis_name": "Serum Cytokine Differential Analysis (MSD) (Stage 2)",
            "analysis_data": [
                "data_5"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT+7",
                "stage": "stage_2"
            }
        },
        {
            "id": "analysis_25",
            "analysis_name": "Viral Load (Ctmin) Comparison Analysis (Stage 2)",
            "analysis_data": [
                "data_7"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT+7",
                "stage": "stage_2"
            }
        },
        {
            "id": "analysis_26",
            "analysis_name": "CIBERSORTx Cell Abundance Analysis (Stage 2)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_2"
            }
        },
        {
            "id": "analysis_27",
            "analysis_name": "Global miRNA Downregulation Analysis (Stage 2)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_2"
            }
        },
        {
            "id": "analysis_28",
            "analysis_name": "snoRNA-derived sRNA Temporal Expression Analysis (Stage 2)",
            "analysis_data": [
                "data_3"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": [
                    "CT",
                    "CT+7"
                ],
                "stage": "stage_2"
            }
        },
        {
            "id": "analysis_29",
            "analysis_name": "Absence of Th2-Skewed Immune Response Analysis (Stage 2)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_2"
            }
        },
        {
            "id": "analysis_30",
            "analysis_name": "Longitudinal Gene Expression Trajectory Analysis (Stage 1)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": [
                    "NAAT+ve",
                    "NAAT-ve"
                ],
                "time_point": "D0, CT, CT+7",
                "stage": "stage_1"
            }
        },
        {
            "id": "analysis_31",
            "analysis_name": "Cell-Type-Specific Differential Expression Analysis (Stage 2)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "gene": "KREMEN1",
                "cell_type": "neutrophils",
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_2"
            }
        },
        {
            "id": "analysis_32",
            "analysis_name": "MiRNA-mRNA Reciprocal Enrichment Analysis (Stage 2)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "omics_layers": [
                    "mRNA",
                    "miRNA"
                ],
                "enrichment_type": "opposite and same",
                "time_point": "CT",
                "stage": "stage_2"
            }
        },
        {
            "id": "analysis_33",
            "analysis_name": "Blood Transcriptional Module (BTM) Analysis (Stage 2)",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_2",
                "pathway": [
                    "humoral immune response",
                    "complement regulation"
                ]
            }
        },
        {
            "id": "analysis_34",
            "analysis_name": "Leukocyte and Platelet Count Analysis (Stage 1)",
            "analysis_data": [
                "data_8"
            ],
            "label": {
                "vaccine_group": [
                    "ChAdOx1 nCoV-19",
                    "Placebo"
                ],
                "naat_status": "NAAT+ve",
                "time_point": "CT",
                "stage": "stage_1"
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": "number_of_DEGs",
            "value": "1119",
            "features": []
        },
        {
            "analysis_id": "analysis_1",
            "metrics": "log2_fold_change",
            "value": "higher in NAAT+ve placebo group",
            "features": [
                "response to virus",
                "type I interferon"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "FDR",
            "value": "0.026 (response to virus), 0.0001 (type I interferon)",
            "features": [
                "response to virus",
                "type I interferon"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "clustering",
            "value": "distinct molecular signatures between groups",
            "features": [
                "NAAT+ve",
                "NAAT-ve",
                "baseline"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "number_of_DEGs",
            "value": "5",
            "features": []
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "log2_fold_change",
            "value": "higher in placebo group",
            "features": [
                "KREMEN1",
                "MX1-201 isoform"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "expression",
            "value": "upregulated in placebo group",
            "features": [
                "MX1-201 isoform"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "enrichment",
            "value": "positive",
            "features": [
                "humoral immune response",
                "complement regulation"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "fold_change",
            "value": "higher in NAAT+ve placebo group",
            "features": [
                "IP10",
                "IL10",
                "MCP1",
                "IL18",
                "TNF-alpha"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "FDR",
            "value": "0.045 (IFN-γ), 0.0035 (IP10), 0.013 (IL10), 0.0057 (TNF-α)",
            "features": [
                "IFN-γ",
                "IP10",
                "IL10",
                "TNF-α"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "cell_abundance_difference",
            "value": "lower neutrophil abundance in placebo group",
            "features": [
                "neutrophils"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "neutropenia_incidence",
            "value": "16%",
            "features": [
                "neutrophils"
            ]
        },
        {
            "analysis_id": "analysis_9",
            "metrics": "enrichment_p_value",
            "value": "0.01 (negative regulation of interleukin-1-mediated signaling pathway)",
            "features": [
                "negative regulation of interleukin-1-mediated signaling pathway"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "overlap",
            "value": "differentially expressed serum cytokines, the differentially expressed RNAs that encode them and the miRNAs that target their mRNAs",
            "features": [
                "TNF-alpha",
                "IFN-gamma",
                "Coronavirus Disease COVID-19 pathway"
            ]
        },
        {
            "analysis_id": "analysis_11",
            "metrics": "proportion_test_p_value",
            "value": "2.2 × 10⁻¹⁵",
            "features": [
                "Coronavirus Disease COVID-19 pathway"
            ]
        },
        {
            "analysis_id": "analysis_12",
            "metrics": "enrichment_p_value",
            "value": "0.01",
            "features": [
                "Coronavirus Disease COVID-19 pathway"
            ]
        },
        {
            "analysis_id": "analysis_13",
            "metrics": "expression_difference",
            "value": "5 sRNAs differentially expressed in ChAdOx1 nCoV-19 group",
            "features": [
                "snoRNA-derived sRNAs"
            ]
        },
        {
            "analysis_id": "analysis_14",
            "metrics": "enrichment_p_value",
            "value": "0.016",
            "features": [
                "humoral immune response"
            ]
        },
        {
            "analysis_id": "analysis_15",
            "metrics": "enrichment_direction",
            "value": "positive",
            "features": [
                "B cell-related pathways",
                "CD4 T cell pathways"
            ]
        },
        {
            "analysis_id": "analysis_16",
            "metrics": "expression_level",
            "value": "downregulated",
            "features": [
                "DICER",
                "AGO3",
                "AGO1",
                "AGO2"
            ]
        },
        {
            "analysis_id": "analysis_17",
            "metrics": "isoform_expression",
            "value": "upregulated in placebo group",
            "features": [
                "MX1-201 isoform"
            ]
        },
        {
            "analysis_id": "analysis_18",
            "metrics": "p_value",
            "value": "0.79 (stage 1), 0.93 (stage 2), 0.93 (overall)",
            "features": [
                "Ctmin values"
            ]
        },
        {
            "analysis_id": "analysis_19",
            "metrics": "median_crp",
            "value": "3.7 (placebo), 3.85 (ChAdOx1 nCoV-19)",
            "features": [
                "CRP levels"
            ]
        },
        {
            "analysis_id": "analysis_20",
            "metrics": "anticorrelation",
            "value": "yes",
            "features": [
                "hsa-miR-150-5p",
                "STAT1"
            ]
        },
        {
            "analysis_id": "analysis_21",
            "metrics": "expression_difference",
            "value": "KREMEN1 downregulated in neutrophils of placebo group",
            "features": [
                "KREMEN1",
                "neutrophils"
            ]
        },
        {
            "analysis_id": "analysis_22",
            "metrics": "number_of_DEGs",
            "value": "5644 (placebo), 1538 (ChAdOx1 nCoV-19)",
            "features": []
        },
        {
            "analysis_id": "analysis_23",
            "metrics": "enrichment_p_value",
            "value": "positive",
            "features": [
                "humoral immune response"
            ]
        },
        {
            "analysis_id": "analysis_24",
            "metrics": "expression_difference",
            "value": "snoRNA-derived sRNAs upregulated earlier in ChAdOx1 nCoV-19 group",
            "features": [
                "snoRNA-derived sRNAs"
            ]
        },
        {
            "analysis_id": "analysis_25",
            "metrics": "fold_change",
            "value": "higher in NAAT+ve placebo group",
            "features": [
                "IP10",
                "IL10",
                "MCP1",
                "IL18",
                "TNF-alpha"
            ]
        },
        {
            "analysis_id": "analysis_25",
            "metrics": "FDR",
            "value": "0.042 (IFN-γ), 0.019 (IL18), 0.0035 (IP10), 0.013 (IL10), 0.0057 (TNF-α)",
            "features": [
                "IFN-γ",
                "IP10",
                "IL10",
                "TNF-α"
            ]
        },
        {
            "analysis_id": "analysis_26",
            "metrics": "p_value",
            "value": "0.93",
            "features": [
                "Ctmin values"
            ]
        },
        {
            "analysis_id": "analysis_27",
            "metrics": "cell_type_specific_expression",
            "value": "lower neutrophil abundance in placebo group",
            "features": [
                "neutrophils"
            ]
        },
        {
            "analysis_id": "analysis_28",
            "metrics": "cell_count_difference",
            "value": "lower neutrophil, lymphocyte, monocyte, basophil, eosinophil, and platelet counts in placebo group",
            "features": [
                "neutrophils",
                "lymphocytes",
                "monocytes",
                "basophils",
                "eosinophils",
                "platelets"
            ]
        },
        {
            "analysis_id": "analysis_29",
            "metrics": "expression_difference",
            "value": "snoRNA-derived sRNAs upregulated earlier in ChAdOx1 nCoV-19 group",
            "features": [
                "snoRNA-derived sRNAs"
            ]
        },
        {
            "analysis_id": "analysis_30",
            "metrics": "trajectory_resolution",
            "value": "returned toward baseline",
            "features": [
                "Coronavirus Disease COVID-19 pathway",
                "hsa-miR-150-5p",
                "STAT1"
            ]
        },
        {
            "analysis_id": "analysis_31",
            "metrics": "enrichment_p_value",
            "value": "0.016 (response to virus)",
            "features": [
                "response to virus"
            ]
        },
        {
            "analysis_id": "analysis_32",
            "metrics": "enrichment_p_value",
            "value": "0.016",
            "features": [
                "interferon-gamma-mediated signaling pathway"
            ]
        },
        {
            "analysis_id": "analysis_33",
            "metrics": "enrichment",
            "value": "positive",
            "features": [
                "humoral immune response",
                "complement regulation"
            ]
        }
    ]
}